Literature DB >> 26920497

Early silent microstructural degeneration and atrophy of the thalamocortical network in multiple sclerosis.

Michael Deppe1, Julia Krämer1, Jan-Gerd Tenberge1, Jasmin Marinell1, Wolfram Schwindt2, Katja Deppe3, Sergiu Groppa4, Heinz Wiendl1, Sven G Meuth1.   

Abstract

Recent studies on patients with clinically isolated syndrome (CIS) and multiple sclerosis (MS) demonstrated thalamic atrophy. Here we addressed the following question: Is early thalamic atrophy in patients with CIS and relapsing-remitting MS (RRMS) mainly a direct consequence of white matter (WM) lesions-as frequently claimed-or is the atrophy stronger correlated to "silent" (nonlesional) microstructural thalamic alterations? One-hundred and ten patients with RRMS, 12 with CIS, and 30 healthy controls were admitted to 3 T magnetic resonance imaging. Fractional anisotropy (FA) was computed from diffusion tensor imaging (DTI) to assess thalamic and WM microstructure. The relative thalamic volume (RTV) and thalamic FA were significantly reduced in patients with CIS and RRMS relative to healthy controls. Both measures were also correlated. The age, gender, WM lesion load, thalamic FA, and gray matter volume-corrected RTV were reduced even in the absence of thalamic and extensive white matter lesions-also in patients with short disease duration (≤24 months). A voxel-based correlation analysis revealed that the RTV reduction had a significant effect on local WM FA-in areas next to the thalamus and basal ganglia. These WM alterations could not be explained by WM lesions, which had a differing spatial distribution. Early thalamic atrophy is mainly driven by silent microstructural thalamic alterations. Lesions do not disclose the early damage of thalamocortical circuits, which seem to be much more affected in CIS and RRMS than expected. Thalamocortical damage can be detected by DTI in normal appearing brain tissue. Hum Brain Mapp 37:1866-1879, 2016.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  DTI; MRI; atrophy; clinically isolated syndrome; fractional anisotropy; multiple sclerosis; neurodegeneration; silent disease activity; thalamocortical network; thalamus

Mesh:

Substances:

Year:  2016        PMID: 26920497      PMCID: PMC6867391          DOI: 10.1002/hbm.23144

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  44 in total

1.  Are thalamocortical rhythms the Rosetta Stone of a subset of neurological disorders?

Authors:  D A McCormick
Journal:  Nat Med       Date:  1999-12       Impact factor: 53.440

2.  High-resolution intersubject averaging and a coordinate system for the cortical surface.

Authors:  B Fischl; M I Sereno; R B Tootell; A M Dale
Journal:  Hum Brain Mapp       Date:  1999       Impact factor: 5.038

3.  Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis.

Authors:  Sonia Batista; Robert Zivadinov; Marietta Hoogs; Niels Bergsland; Mari Heininen-Brown; Michael G Dwyer; Bianca Weinstock-Guttman; Ralph H B Benedict
Journal:  J Neurol       Date:  2011-07-01       Impact factor: 4.849

4.  Thalamocortical dysrhythmia: A neurological and neuropsychiatric syndrome characterized by magnetoencephalography.

Authors:  R R Llinás; U Ribary; D Jeanmonod; E Kronberg; P P Mitra
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

5.  Atrophy mainly affects the limbic system and the deep grey matter at the first stage of multiple sclerosis.

Authors:  Bertrand Audoin; Wafaa Zaaraoui; Françoise Reuter; Audrey Rico; Irina Malikova; Sylviane Confort-Gouny; Patrick J Cozzone; Jean Pelletier; Jean-Philippe Ranjeva
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-04-14       Impact factor: 10.154

6.  Measuring the thickness of the human cerebral cortex from magnetic resonance images.

Authors:  B Fischl; A M Dale
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

7.  Thalamic atrophy and cognition in multiple sclerosis.

Authors:  M K Houtchens; R H B Benedict; R Killiany; J Sharma; Z Jaisani; B Singh; B Weinstock-Guttman; C R G Guttmann; R Bakshi
Journal:  Neurology       Date:  2007-09-18       Impact factor: 9.910

8.  Iron content of the pulvinar nucleus of the thalamus is increased in adolescent multiple sclerosis.

Authors:  Jesper Hagemeier; E Ann Yeh; Mari Heininen Brown; Niels Bergsland; Michael G Dwyer; Ellen Carl; Bianca Weinstock-Guttman; Robert Zivadinov
Journal:  Mult Scler       Date:  2012-09-11       Impact factor: 6.312

9.  Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations.

Authors:  O Ciccarelli; D J Werring; C A Wheeler-Kingshott; G J Barker; G J Parker; A J Thompson; D H Miller
Journal:  Neurology       Date:  2001-04-10       Impact factor: 9.910

Review 10.  Gray matter imaging in multiple sclerosis: what have we learned?

Authors:  Hanneke E Hulst; Jeroen J G Geurts
Journal:  BMC Neurol       Date:  2011-12-12       Impact factor: 2.474

View more
  17 in total

Review 1.  The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.

Authors:  Kedar R Mahajan; Daniel Ontaneda
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

2.  Effects of Axonal Demyelination, Inflammatory Cytokines and Divalent Cation Chelators on Thalamic HCN Channels and Oscillatory Bursting.

Authors:  Tengiz Oniani; Laura Vinnenberg; Rahul Chaudhary; Julian A Schreiber; Kathrin Riske; Brandon Williams; Hans-Christian Pape; John A White; Anna Junker; Guiscard Seebohm; Sven G Meuth; Petra Hundehege; Thomas Budde; Mehrnoush Zobeiri
Journal:  Int J Mol Sci       Date:  2022-06-03       Impact factor: 6.208

3.  Network alterations underlying anxiety symptoms in early multiple sclerosis.

Authors:  Erik Ellwardt; Muthuraman Muthuraman; Gabriel Gonzalez-Escamilla; Venkata Chaitanya Chirumamilla; Felix Luessi; Stefan Bittner; Frauke Zipp; Sergiu Groppa; Vinzenz Fleischer
Journal:  J Neuroinflammation       Date:  2022-05-24       Impact factor: 9.587

4.  ISGylation is induced in neurons by demyelination driving ISG15-dependent microglial activation.

Authors:  Benjamin D S Clarkson; Ethan Grund; Kenneth David; Renee K Johnson; Charles L Howe
Journal:  J Neuroinflammation       Date:  2022-10-20       Impact factor: 9.587

5.  Modulation of pacemaker channel function in a model of thalamocortical hyperexcitability by demyelination and cytokines.

Authors:  Rahul Chaudhary; Stefanie Albrecht; Maia Datunashvili; Manuela Cerina; Annika Lüttjohann; Ye Han; Venu Narayanan; Dane M Chetkovich; Tobias Ruck; Tanja Kuhlmann; Hans-Christian Pape; Sven G Meuth; Mehrnoush Zobeiri; Thomas Budde
Journal:  Cereb Cortex       Date:  2022-10-08       Impact factor: 4.861

6.  Quantitative Susceptibility Mapping of the Thalamus: Relationships with Thalamic Volume, Total Gray Matter Volume, and T2 Lesion Burden.

Authors:  G C Chiang; J Hu; E Morris; Y Wang; S A Gauthier
Journal:  AJNR Am J Neuroradiol       Date:  2018-01-25       Impact factor: 3.825

7.  Non-lesional cerebellar damage in patients with clinically isolated syndrome: DTI measures predict early conversion into clinically definite multiple sclerosis.

Authors:  Alexa V Kugler; Michael Deppe
Journal:  Neuroimage Clin       Date:  2018-04-24       Impact factor: 4.881

8.  Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging.

Authors:  Svetlana Bezukladova; Jouni Tuisku; Markus Matilainen; Anna Vuorimaa; Marjo Nylund; Sarah Smith; Marcus Sucksdorff; Mehrbod Mohammadian; Virva Saunavaara; Sini Laaksonen; Johanna Rokka; Juha O Rinne; Eero Rissanen; Laura Airas
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-03-02

9.  Alemtuzumab Improves Cognitive Processing Speed in Active Multiple Sclerosis-A Longitudinal Observational Study.

Authors:  Ester Riepl; Steffen Pfeuffer; Tobias Ruck; Hubertus Lohmann; Heinz Wiendl; Sven G Meuth; Andreas Johnen
Journal:  Front Neurol       Date:  2018-01-16       Impact factor: 4.003

10.  Differential Gray Matter Vulnerability in the 1 Year Following a Clinically Isolated Syndrome.

Authors:  Ismail Koubiyr; Mathilde Deloire; Pierrick Coupé; Cécile Dulau; Pierre Besson; Amandine Moroso; Vincent Planche; Thomas Tourdias; Bruno Brochet; Aurélie Ruet
Journal:  Front Neurol       Date:  2018-10-11       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.